SEC FORM 4
$85,517.64
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Sale of 18,273 shares at $4.68 per share.
Reporting Person Reynoso Jamie L. · Officer Title CEO, Medicare Advantage · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 19, 2026
Source: SEC Form 4 · 0001801170-26-000276 · filed 2026-10-19 · View filing →